Download PDF
Open Access
CC BY-NC-ND 4.0 · Indian J Med Paediatr Oncol 2013; 34(02): 117-120
DOI: 10.4103/0971-5851.116202
CASE REPORT

Oesophageal carcinoma presenting with a synchronous asymptomatic colon carcinoma

Authors

  • Alok Gupta

    Department of Medical Oncology, Tata Memorial Hospital, Mumbai, Maharashtra, India

  • Bharat Chauhan

    Department of Medical Oncology, Tata Memorial Hospital, Mumbai, Maharashtra, India

  • V Rangarajan

    Department of Nuclear Medicine, Tata Memorial Hospital, Mumbai, Maharashtra, India

  • Saral Desai

    Department of Pathology, Tata Memorial Hospital, Mumbai, Maharashtra, India

  • Vanita Noronha

    Department of Medical Oncology, Tata Memorial Hospital, Mumbai, Maharashtra, India

  • Kumar Prabhash

    Department of Medical Oncology, Tata Memorial Hospital, Mumbai, Maharashtra, India
Further Information
Also available at
 PDF Download Permissions and Reprints
Preview

Abstract

The advancement in diagnostic techniques has resulted in increased incidence of occult second primary in cancer patients. Here, we report a case of symptomatic oesophageal carcinoma and synchronous asymptomatic colon carcinoma diagnosed through Positron Emission Tomography-Computed Tomography imaging.

Keywords

Multiple primary malignant neoplasms - oesophageal carcinoma - synchronous colon carcinoma


Publication History

Article published online:
20 July 2021

© 2013. Indian Society of Medical and Paediatric Oncology. This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial-License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/.)

Thieme Medical and Scientific Publishers Pvt. Ltd.
A-12, 2nd Floor, Sector 2, Noida-201301 UP, India

 

  • References

  • 1 Billroth T. Die Allgemeine Chirurgische Pathologie and Therapie. In: Reimer G, Editor. 51 Vorlesungen-Ein Handbuch fur Studierende and Artze. 14. Vol. 8. xx, Berlin: Auflage; 1889. p. 712.
  • 2 Demandante CG, Troyer DA, Miles TP. Multiple primary malignant neoplasms: Case report and a comprehensive review of the literature. Am J Clin Oncol 2003;26:79-83.
  • 3 Aydiner A, Karadeniz A, Uygun K, Tas S, Tas F, Disci R, et al. Multiple primary neoplasms at a single institution: Differences between synchronous and metachronous neoplasms. Am J Clin Oncol 2000;23:364-70.
  • 4 Vyas JJ, Deshpande RK, Sharma S, Desai PB. Multiple primary cancers in Indian population: Metachronous and synchronous lesions. J Surg Oncol 1983;23:239-49.
  • 5 Luciani A, Balducci L. Multiple primary malignancies. Semin Oncol 2004;31:264-73.
  • 6 Kilciksiz S, Gokce T, Baloglu A, Calli A, Kaynak C, Kilic B, et al. Characteristics of synchronous- and metachronous-type multiple primary neoplasms: A study of hospital-based cancer registry in Turkey. Clin Genitourin Cancer 2007;5:438-45.
  • 7 Crocetti E, Arniani S, Buiatti E. Synchronous and metachronous diagnosis of multiple primary cancers. Tumori 1998;84:9-13.
  • 8 Koutsopoulos AV, Dambaki KI, Datseris G, Giannikaki E, Froudarakis M, Stathopoulos E. A novel combination of multiple primary carcinomas: Urinary bladder transitional cell carcinoma, prostate adenocarcinoma and small cell lung carcinoma: Report of a case and review of the literature. World J Surg Oncol 2005;3:51.
  • 9 Artac M, Bozcuk H, Ozdogan M, Demiral AN, Sarper A, Samur M, et al. Different clinical features of primary and secondary tumors in patients with multiple malignancies. Tumori 2005;91:317-20.
  • 10 Hemminki K, Boffetta P. Multiple primary cancers as clues to environmental and heritable causes of cancer and mechanisms of carcinogenesis. IARC Sci Publ 2004;157:289-97.
  • 11 Carey TE. Field cancerization: Are multiple primary cancers monoclonal or polyclonal? Ann Med 1996;28:183-8.
  • 12 Kotnis A, Kannan S, Sarin R, Mulherkar R. Case-control study and meta-analysis of SULT1A1 Arg213His polymorphism for gene, ethnicity and environment interaction for cancer risk. Br J Cancer 2008;99:1340-7.
  • 13 Sontag SJ, Schnell TG, Chejfec G, O′Connell S, Stanley MM, Best W, et al. Barrett′s oesophagus and colonic tumours. Lancet 1985;1:946-9.
  • 14 Laitakari R, Laippala P, Isolauri J. Barrett′s oesophagus is not a risk factor for colonic neoplasia: A case-control study. Ann Med 1995;27:499-502.
  • 15 Watanabe Y, Tsutsui M, Takeda S, Yoshino S, Oka M. A case of esophageal cancer associated with colon cancer successfully treated with combination chemotherapy of FOLFOX and concurrent radiotherapy. Gan To Kagaku Ryoho 2009;36:2439-41.
  • 16 Morgan G, Vainio H. Barrett′s oesophagus, oesophageal cancer and colon cancer: An explanation of the association and cancer chemopreventive potential of non-steroidal anti-inflammatory drugs. Eur J Cancer Prev 1998;7:195-9.
  • 17 Weber WA, Ott K, Becker K, Dittler HJ, Helmberger H, Avril NE, et al. Prediction of response to preoperative chemotherapy in adenocarcinomas of the esophagogastric junction by metabolic imaging. J Clin Oncol 2001;19:3058-65.
  • 18 Suzuki S, Nishimaki T, Suzuki T, Kanda T, Nakagawa S, Hatakeyama K. Outcomes of simultaneous resection of synchronous esophageal and extraesophageal carcinomas. J Am Coll Surg 2002;195:23-9.